Drug Approval | April 18, 2022
Lupin receives tentative approval from USFDA for Tenofovir Alafenamide Tablets
This product will be manufactured at Lupin’s Nagpur facility in India
This product will be manufactured at Lupin’s Nagpur facility in India
The drug will be manufactured at the group's injectables manufacturing facility at Jarod, Gujarat
The HD-550 endoscopy system has been available outside of the USA since 2019
Fujifilm’s NEVER STOP philosophy to enhance the access to healthcare for all Indians
Dr. Mansukh Mandaviya launches a quarterly report on AB-HWCs, Guidelines on Human resources for health, Public Health Management Cadre’ Guidance for implementation and Indian Public Health Standards Guidelines; interacts with healthcare workers from across the country
The minister exhorted the pharmaceutical sector to prepare a plan for the next 25 years
The product will be manufactured at Lupin’s facility in Goa, India
Ocular hypertension affects over 5% of all adults; the eye does not properly drain fluid, causing eye pressure to build up
An RMAT confers eligibility for accelerated approval and priority review of biologics licensing applications (BLA)
Turn has developed a novel cell rejuvenating platform with significant potential for application in an array of age-related diseases
Subscribe To Our Newsletter & Stay Updated
